ArticleAssessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
ArticleAssessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleImmunohistochemical Sox2 expression in lung squamous cell carcinoma and adenocarcinoma stage III-IV
ArticleImmunohistochemical Sox2 expression in lung squamous cell carcinoma and adenocarcinoma stage III-IV
ArticleRole of YAP1 and tumor-associated macrophages in urothelial carcinoma of urinary bladder: Histopathological and immunohistochemical studies
ArticleRole of YAP1 and tumor-associated macrophages in urothelial carcinoma of urinary bladder: Histopathological and immunohistochemical studies
ArticleSignificance of Expression of IMP3, PPARG & PD-L1 in Urothelial Carcinoma (Immunohistochemical Study)
ArticleSignificance of Expression of IMP3, PPARG & PD-L1 in Urothelial Carcinoma (Immunohistochemical Study)
ArticleGATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance
ArticleGATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance
ArticleKeratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma
ArticleKeratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma
ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics
ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics